Insightec’s neurosurgery solution, Exablate Neuro, is the first focused ultrasound device approved by the FDA to treat patients with essential tremor. Exablate Neuro is a non-invasive, image-guided personalized thalamotomy, treated through an intact skull that doesn't require any ionizing radiation, incisions or implants.

What is Exablate Neuro?

High intensity focused ultrasound waves precisely target a focal point in the Vim nucleus of the thalamus, the tiny part of the brain that is thought to be responsible for causing tremors. The Exablate Neuro ultrasound transducer consists of 1024 beams that generate enough heat to ablate the targeted tissue during treatment. The result is an immediate and significant reduction of tremor for patients.

During planning and treatment for essential tremor, the patient is fully conscious and lying on the treatment bed in an MRI scanner. MRI provides high resolution visualization, patient-specific treatment planning and continuous monitoring of the procedure. Real-time thermal feedback allows the physician to control and adjust the treatment, ensuring that the targeted tissue is completely ablated without impacting adjacent healthy tissue.

This revolutionary, non-invasive treatment offers a life changing treatment to patients with essential tremor.

View our treatment centers

How IT Works

Exablate Neuro is a non-invasive, image-guided alternative for deep brain lesioning

FDA labelling

Exablate Neuro is approved for the non-invasive treatment of essential tremor in patients who have not responded to medication.

    • Essential Tremor
      Read More close

Why INSIGHTEC Neurosurgery?

  • Clinical Value

    Non-invasive, no penetrating trajectories and no ionizing radiation. Real time MRI for targeting and thermal feedback. Sharp, accurate treatment that allows for lesions as small as 2mm.

  • Patient Value

    No craniotomy, immediate results, minimal risk of infection, bleeding or other surgical complications. Single session treatment, no anesthesia, quick recovery and no implanted hardware.

  • Operational efficiency

    Short hospitalization. Medical facilities can attract and treat additional patient groups and strengthen their hospital/clinic leadership in innovation and advanced care.

Physician Testimonials

Prof. Takaomi Taira, Director of Stereotactic and Functional Neurosurgery, Dep. Of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan, shares his insights regarding the advantages of Exablate MRgFUS technology in treating movement disorders, and the witnessed change in patients’ quality of life.

Regulatory Approvals

Per Indication


Please fill all the following details and we will get in touch with you (* Required)

agreement Error

Thank You!

Thank you for contacting us! We will get back to you shortly.

Thank You!

This site is brought to you by INSIGHTEC, © 2016 Insightec Ltd. All rights reserved

NGSoft logo